ConductScience.org, home

Paper6133417

Mechanism and basis for specificity of transglutaminase-catalyzed epsilon-(gamma-glutamyl) lysine bond formation.

Folk JE. Adv Enzymol Relat Areas Mol Biol, 1983. Cited by 263 papers, by iCite.

Cite this record

ConductScience Library. Mechanism and basis for specificity of transglutaminase-catalyzed epsilon-(gamma-glutamyl) lysine bond formation. Papers, record 6133417. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6133417

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Mechanism and basis for specificity of transglutaminase-catalyzed epsilon-(gamma-glutamyl) lysine bond formation.
PubMed
Journal
Adv Enzymol Relat Areas Mol Biol
PubMed
Year
1983
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
263
iCite
Relative citation ratio, by iCite
7.06
iCite
Revised in PubMed
2019-10-31
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Folk JEJ E

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AcyltransferasesMajor topic
DipeptidesMajor topic
Amides
Animals
Binding Sites
Factor XIII
Guinea Pigs
Humans
Kinetics
Liver
Substrate Specificity
Transglutaminases

Source PubMed

Download CSV of topics

Cited by56

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 263 citations.

PMIDTitleJournalYearIn PapersSource
42533401Beyond Sequence: Posttranslational Remodeling of Antigens in Autoimmunity.Immunol Rev2026https://conductscience.org/library/papers/42533401PubMed
42087096Beyond neurotransmission: the roles of serotonylation in physiological and pathological processes.Cell Mol Biol Lett2026https://conductscience.org/library/papers/42087096PubMed
41490984Targeting the Primordial Chaperone to Overcome Acquired Drug Resistance in Cancer: TG2-Mediated Autophagy.Biomol Ther (Seoul)2026https://conductscience.org/library/papers/41490984PubMed
41129518Efficient two-step chemoenzymatic conjugation of antibody fragments with reporter compounds by a specific thiol-PEG-amine Linker, HS-PEG-NH2.PLoS One2025https://conductscience.org/library/papers/41129518PubMed
35642005Ethacrynic acid is an inhibitor of human factor XIIIa.BMC Pharmacol Toxicol2022https://conductscience.org/library/papers/35642005PubMed
32708896Transglutaminase 2-Mediated p53 Depletion Promotes Angiogenesis by Increasing HIF-1α-p300 Binding in Renal Cell Carcinoma.Int J Mol Sci2020https://conductscience.org/library/papers/32708896PubMed
32560270Inhibition of Transglutaminase 2 but Not of MDM2 Has a Significant Therapeutic Effect on Renal Cell Carcinoma.Cells2020https://conductscience.org/library/papers/32560270PubMed
32548124Intestinal Anti-tissue Transglutaminase2 Autoantibodies: Pathogenic and Clinical Implications for Celiac Disease.Front Nutr2020https://conductscience.org/library/papers/32548124PubMed
32502864Factor XIIIa inhibitors as potential novel drugs for venous thromboembolism.Eur J Med Chem2020https://conductscience.org/library/papers/32502864PubMed
32367038Identification of Isopeptides Between Human Tissue Transglutaminase and Wheat, Rye, and Barley Gluten Peptides.Sci Rep2020https://conductscience.org/library/papers/32367038PubMed
31407850Proteolytic and nonproteolytic activation mechanisms result in conformationally and functionally different forms of coagulation factor XIII A.FEBS J2020https://conductscience.org/library/papers/31407850PubMed
30761263Optimised methods (SDS/PAGE and LC-MS) reveal deamidation in all examined transglutaminase-mediated reactions.FEBS Open Bio2019https://conductscience.org/library/papers/30761263PubMed
30229425Hispanic Spinocerebellar Ataxia Type 35 (SCA35) with a Novel Frameshift Mutation.Cerebellum2019https://conductscience.org/library/papers/30229425PubMed
29362136The diamond anniversary of tissue transglutaminase: a protein of many talents.Drug Discov Today2018https://conductscience.org/library/papers/29362136PubMed
27784785Epitope-dependent Functional Effects of Celiac Disease Autoantibodies on Transglutaminase 2.J Biol Chem2016https://conductscience.org/library/papers/27784785PubMed
24888439Dihydroisoxazole inhibitors of Anopheles gambiae seminal transglutaminase AgTG3.Malar J2014https://conductscience.org/library/papers/24888439PubMed
24351005Injectable gel graft for bone defect repair.Regen Med2014https://conductscience.org/library/papers/24351005PubMed
23288850Characterization of Anopheles gambiae transglutaminase 3 (AgTG3) and its native substrate Plugin.J Biol Chem2013https://conductscience.org/library/papers/23288850PubMed
23193435Transglutaminase inhibition: A therapy to protect cells from death in neurodegeneration?World J Biol Chem2012https://conductscience.org/library/papers/23193435PubMed
22606367Celiac disease, inflammation and oxidative damage: a nutrigenetic approach.Nutrients2012https://conductscience.org/library/papers/22606367PubMed

See all 56 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6133417

GET https://conductscience.org/api/papers/v1/6133417/cited_by?page=2